Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Broderick

Showing results (31-40 of 83) with videos related to

Pageof 9
Sort By:
Stroke|September 1, 1992
Relationship of cardiac disease to stroke occurrence, recurrence, and mortalityJ P Broderick, S J Phillips, W M O'Fallon, et al.
Neuroscience|April 24, 2012
Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusionY Suofu, J F Clark, J P Broderick, et al.
Stroke|October 1, 1991
Epidemiological characteristics of lacunar infarcts in a populationS E Sacco, J P Whisnant, J P Broderick, et al.
Stroke|May 1, 1989
Incidence rates of stroke in the eighties: the end of the decline in stroke?J P Broderick, S J Phillips, J P Whisnant, et al.
AJNR. American Journal of Neuroradiology|September 15, 2006
Using the baseline CT scan to select acute stroke patients for IV-IA therapyM D Hill, A M Demchuk, T A Tomsick, et al.
Neurology|September 30, 2009
Good clinical outcome after ischemic stroke with successful revascularization is time-dependentP Khatri, T Abruzzo, S D Yeatts, et al.
Neuroscience|September 17, 2013
Matrix metalloproteinase-2 deletions protect against hemorrhagic transformation after 1 h of cerebral ischemia and 23 h of reperfusionA Lu, Y Suofu, F Guan, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|September 27, 2007
Recent advances in stroke managementG W Albers, M J Alberts, J P Broderick, et al.
Neurology|August 30, 2008
How important is surrogate consent for stroke research?M L Flaherty, J Karlawish, J C Khoury, et al.
The New England Journal of Medicine|May 11, 2001
Spontaneous intracerebral hemorrhageA I Qureshi, S Tuhrim, J P Broderick, et al.
Pageof 9

Showing results (31-40 of 83) with videos related to

Sort By:
Pageof 9
Stroke|September 1, 1992
Relationship of cardiac disease to stroke occurrence, recurrence, and mortalityJ P Broderick, S J Phillips, W M O'Fallon, et al.
Neuroscience|April 24, 2012
Matrix metalloproteinase-2 or -9 deletions protect against hemorrhagic transformation during early stage of cerebral ischemia and reperfusionY Suofu, J F Clark, J P Broderick, et al.
Stroke|October 1, 1991
Epidemiological characteristics of lacunar infarcts in a populationS E Sacco, J P Whisnant, J P Broderick, et al.
Stroke|May 1, 1989
Incidence rates of stroke in the eighties: the end of the decline in stroke?J P Broderick, S J Phillips, J P Whisnant, et al.
AJNR. American Journal of Neuroradiology|September 15, 2006
Using the baseline CT scan to select acute stroke patients for IV-IA therapyM D Hill, A M Demchuk, T A Tomsick, et al.
Neurology|September 30, 2009
Good clinical outcome after ischemic stroke with successful revascularization is time-dependentP Khatri, T Abruzzo, S D Yeatts, et al.
Neuroscience|September 17, 2013
Matrix metalloproteinase-2 deletions protect against hemorrhagic transformation after 1 h of cerebral ischemia and 23 h of reperfusionA Lu, Y Suofu, F Guan, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|September 27, 2007
Recent advances in stroke managementG W Albers, M J Alberts, J P Broderick, et al.
Neurology|August 30, 2008
How important is surrogate consent for stroke research?M L Flaherty, J Karlawish, J C Khoury, et al.
The New England Journal of Medicine|May 11, 2001
Spontaneous intracerebral hemorrhageA I Qureshi, S Tuhrim, J P Broderick, et al.
Pageof 9